Breakpoints cover image

#69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition

Breakpoints

00:00

Drug Resistant TB - Is Trim Sulfa the Right Agent?

There's been some major updates, both in drug resistant and drug susceptible TB. The B-PAL regimen is quickly becoming standard of care for drug resistant TB but we've got a problem. WHO released a rapid communication and they recommend low dose Linazolid as the standard of care to treat this type of tuberculosis. And those rounds that I had for bacterial infections are really cool.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app